Full Stack Bio brings over 15 years of experience in liquid biopsy test development for oncology and diagnostic assays, most recently
Full Stack Bio will accelerate your test design, prototyping, validation and realization. By substantially de-risking your diagnostic project with Full Stack Bio you will save valuable time and money. This will make it easier to attract growth capital on the most favorable terms when the time is right - based on real-world evidence of performance.
We provide turn-key PCR assays for the rapid and sensitive detection of the SARS CoV-2 virus, the pathogen causing COVID-19.
The test uses CDC-approved sequences and is compatible with real time PCR platforms that include FAM, ROX and HEX dyes.
From concept to realization, we provide test development services for applications in oncology, precision medicine, and infectious diseases.
We will develop your manufacturing roadmap, from proof-of-concept to full GMP production that meets your cost targets and regulatory requirements.
Sign up to hear from us.